Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Renata Silva, Vânia Vilas‐Boas, Helena Carmo, et al.
Pharmacology & Therapeutics (2014) Vol. 149, pp. 1-123
Closed Access | Times Cited: 307

Showing 1-25 of 307 citing articles:

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen, Tianlu Shi, Lei Zhang, et al.
Cancer Letters (2015) Vol. 370, Iss. 1, pp. 153-164
Closed Access | Times Cited: 671
Natural products as multidrug resistance modulators in cancer
Amit Kumar, Vikas Jaitak
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 268-291
Closed Access | Times Cited: 282
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 227
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong, Zuodong Qin, Weidong Zhang, et al.
Drug Resistance Updates (2020) Vol. 49, pp. 100681-100681
Closed Access | Times Cited: 209
Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
Hang Zhang, Hai‐Wei Xu, Charles R. Ashby, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 525-555
Closed Access | Times Cited: 208
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 134
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 130
Factors influencing the blood-brain barrier permeability
Yibin Zhao, Lin Gan, Li Ren, et al.
Brain Research (2022) Vol. 1788, pp. 147937-147937
Open Access | Times Cited: 124
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
Kritika Engle, Gautam Kumar
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114542-114542
Closed Access | Times Cited: 119
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Roberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101205-101205
Open Access | Times Cited: 118
P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators
Yang Guo, Milad Ashrafizadeh, Murtaza M. Tambuwala, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104161-104161
Closed Access | Times Cited: 22
Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review
Dhvani Patel, Nutan Sethi, Paresh Patel, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 198, pp. 114267-114267
Closed Access | Times Cited: 17
Application of Evolutionary Principles to Cancer Therapy
Pedro M. Enríquez‐Navas, Jonathan W. Wojtkowiak, Robert A. Gatenby
Cancer Research (2015) Vol. 75, Iss. 22, pp. 4675-4680
Open Access | Times Cited: 158
Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter
Katarína Elefantová, Boris Lakatoš, Jana Kubíčková, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1985-1985
Open Access | Times Cited: 153
The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy
Raafat El‐Awady, Ekram Saleh, Amna Hashim, et al.
Frontiers in Pharmacology (2017) Vol. 7
Open Access | Times Cited: 132
Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins
Ilaria Genovese, Andrea Ilari, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2017) Vol. 32, pp. 23-46
Open Access | Times Cited: 129
The Evolution and Ecology of Resistance in Cancer Therapy
Robert A. Gatenby, Joel S. Brown
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 8, Iss. 3, pp. a033415-a033415
Open Access | Times Cited: 128
Perplexing Role of P-Glycoprotein in Tumor Microenvironment
Kianna Robinson, Venkataswarup Tiriveedhi
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 125
PGK1-mediated cancer progression and drug resistance.
Yu He, Luo Yang, Dan Zhang, et al.
PubMed (2019) Vol. 9, Iss. 11, pp. 2280-2302
Closed Access | Times Cited: 121
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Eva Gil-Martins, Daniel José Barbosa, Vera Silva, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107554-107554
Closed Access | Times Cited: 119
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Mariline Gameiro, Renata Silva, Carolina Rocha‐Pereira, et al.
Molecules (2017) Vol. 22, Iss. 4, pp. 600-600
Open Access | Times Cited: 106
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods
Maria Miguel Coelho, Carla Fernandes, Fernando Remião, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3113-3113
Open Access | Times Cited: 96
Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
Hao Cheng, Juan Liu, Yuzhu Tan, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 4, pp. 541-555
Open Access | Times Cited: 95
Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma
Kaiming Ren, Ran Xu, Jingshan Huang, et al.
Cancer Chemotherapy and Pharmacology (2017) Vol. 80, Iss. 2, pp. 243-250
Closed Access | Times Cited: 91
Porous Pt nanoparticles loaded with doxorubicin to enable synergistic Chemo-/Electrodynamic Therapy
Tong Chen, Tongxu Gu, Liang Cheng, et al.
Biomaterials (2020) Vol. 255, pp. 120202-120202
Closed Access | Times Cited: 90
Page 1 - Next Page

Scroll to top